112 related articles for article (PubMed ID: 17562328)
1. Synthetic access to spacer-linked 3,6-diamino-2,3,6-trideoxy-alpha-D-glucopyranosides--potential aminoglycoside mimics for the inhibition of the HIV-1 TAR-RNA/Tat-peptide complex.
Jöge T; Jesberger M; Bröker P; Kirschning A
Carbohydr Res; 2007 Sep; 342(12-13):1704-14. PubMed ID: 17562328
[TBL] [Abstract][Full Text] [Related]
2. Amino disaccharides having an alpha-(1-->4) or a beta-(1-->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat.
Iguchi T; Ishikawa H; Matumoto H; Mizuno M; Goto K; Hamasaki K
Nucleic Acids Symp Ser (Oxf); 2005; (49):169-70. PubMed ID: 17150687
[TBL] [Abstract][Full Text] [Related]
3. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
He M; Yuan D; Lin W; Pang R; Yu X; Yang M
Bioorg Med Chem Lett; 2005 Sep; 15(17):3978-81. PubMed ID: 16039124
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine.
Lee CW; Cao H; Ichiyama K; Rana TM
Bioorg Med Chem Lett; 2005 Oct; 15(19):4243-6. PubMed ID: 16054360
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
8. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.
Wang W; Guo Z; Chen Y; Liu T; Jiang L
Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893
[TBL] [Abstract][Full Text] [Related]
9. Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat.
Yajima S; Shionoya H; Akagi T; Hamasaki K
Bioorg Med Chem; 2006 Apr; 14(8):2799-809. PubMed ID: 16413787
[TBL] [Abstract][Full Text] [Related]
10. Neamine dimers targeting the HIV-1 TAR RNA.
Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
[TBL] [Abstract][Full Text] [Related]
11. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
12. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
[TBL] [Abstract][Full Text] [Related]
13. Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs.
Krebs A; Ludwig V; Boden O; Göbel MW
Chembiochem; 2003 Oct; 4(10):972-8. PubMed ID: 14523913
[No Abstract] [Full Text] [Related]
14. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
[TBL] [Abstract][Full Text] [Related]
15. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel beta-carboline derivatives as Tat-TAR interaction inhibitors.
Yu X; Lin W; Li J; Yang M
Bioorg Med Chem Lett; 2004 Jun; 14(12):3127-30. PubMed ID: 15149658
[TBL] [Abstract][Full Text] [Related]
17. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
Yuan D; He M; Pang R; Lin SS; Li Z; Yang M
Bioorg Med Chem; 2007 Jan; 15(1):265-72. PubMed ID: 17055732
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
Yu X; Lin W; Pang R; Yang M
Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
[TBL] [Abstract][Full Text] [Related]
19. Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
Bonnard V; Pascale L; Azoulay S; Di Giorgio A; Rogez-Kreuz C; Storck K; Clayette P; Patino N
Bioorg Med Chem; 2010 Nov; 18(21):7432-8. PubMed ID: 20889349
[TBL] [Abstract][Full Text] [Related]
20. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
Zhao H; Li J; Xi F; Jiang L
FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
